Press Release: European Medicines Agency responds to concerns on its publication of clinical trial data policy

Preview of the European Medicines Agency Management Board meeting on 12 June 2014, in which it was asked to consider a draft policy on the publication of clinical trial data.

The draft policy arises from the Agency’s commitment to increase access to clinical trial data and has been shaped by the many comments we have received during the consultation phase.

• Primary Source

ESO: Background information: European Medicines Agency response to European Ombudsman letter regarding proactive publication of and access to clinical trial data http://www.europeansources.info/record/press-release-european-medicines-agency-response-to-european-ombudsman-letter-regarding-proactive-publication-of-and-access-to-clinical-trial-data/

EurActiv, 11.06.14: Growing concerns over medicines agency's proposed rules for transparency http://www.euractiv.com/sections/health-consumers/growing-concerns-over-medicines-agencys-proposed-rules-transparency-302733

---